DCGI

  • Biocon secures approval to use drug on coronavirus patients
    July 11 (Reuters) - India's Biocon Ltd has received regulatory approval for its drug Itolizumab to be used on coronavirus infected patients suffering from moderate to severe respiratory distress, the biopharmaceutical company said in a statement on Saturday.   The drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in India.   "The randomised control trial indicated that all the